Enliven Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Enliven Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2023.
  • Enliven Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 48.3M shares, a 17.6% increase year-over-year.
  • Enliven Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 35.5M shares, a 1038% increase from 2022.
  • Enliven Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3.12M shares, a 35.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 35.5M +32.4M +1038% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 3.12M +818K +35.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 2.31M Jan 1, 2021 Dec 31, 2021 8-K 2023-06-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.